UNITED STATES And PUERTO RICO — Non-Current Assets

Geographic · Non-Current Assets

Eli Lilly UNITED STATES And PUERTO RICO — Non-Current Assets increased by 40.0% to $18.76B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 40.0%, from $13.40B to $18.76B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2018
Last reportedQ4 2025

How to read this metric

An increase suggests significant capital investment or expansion of manufacturing and research facilities in the region, while a decrease may indicate asset divestitures, depreciation, or a shift in capital allocation strategy.

Detailed definition

This metric represents the total value of long-term assets, such as property, plant, equipment, and intangible assets, a...

Peer comparison

Comparable to regional non-current asset disclosures in other multinational pharmaceutical companies, reflecting the geographic distribution of production and R&D infrastructure.

Metric ID: lly_segment_unitedstates_and_puertorico_noncurrent_assets

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$6.62B$7.71B$9.99B$13.40B$18.76B
QoQ Change+16.5%+29.6%+34.1%+40.0%
YoY Change+16.5%+29.6%+34.1%+40.0%
Range$6.62B$18.76B
CAGR+183.4%
Avg YoY Growth+30.0%
Median YoY Growth+31.9%
Current Streak4+ quarters growth

Frequently Asked Questions

What is Eli Lilly's united states and puerto rico — non-current assets?
Eli Lilly (LLY) reported united states and puerto rico — non-current assets of $18.76B in Q4 2025.
How has Eli Lilly's united states and puerto rico — non-current assets changed year-over-year?
Eli Lilly's united states and puerto rico — non-current assets increased by 40.0% year-over-year, from $13.40B to $18.76B.
What does united states and puerto rico — non-current assets mean?
The total value of long-term assets held by the company within its United States and Puerto Rico operations.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.